Ashton Thomas Private Wealth’s BioStem Technologies BSEM Stock Holding History

Ashton Thomas Private Wealth’s Portfolio BSEM Stock Details BSEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$31.1K	Buy	+10,078	New	+$38.3K	﹤0.01%	1477

Other funds holding BSEM

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Atlantic Union Bankshares Glen Allen, Virginia $6.11B AUM 17.62% 1-Year Est. Return

Gables Capital Management Miami, Florida $267M AUM 34.53% 1-Year Est. Return

Wolff Wiese Magana Carslbad, California $218M AUM 37.48% 1-Year Est. Return

Birchbrook Bangor, Maine $209M AUM 12.33% 1-Year Est. Return

Global Retirement Partners San Rafael, California $7.1B AUM

Ashton Thomas Private Wealth's BSEM Position: Q3 2026 in Review

Ashton Thomas Private Wealth opened a new position in BioStem Technologies (BSEM) in Q3 2026: 10,078 shares worth $31.1K. The stake represents ﹤0.01% of the portfolio and ranks #1477 among its holdings.

13 funds tracked by Wall St. Rank hold BSEM as of Q3 2026.

Ashton Thomas Private Wealth held 10,078 shares of BioStem Technologies worth $31.1K as of Q3 2026.
BioStem Technologies was a new Ashton Thomas Private Wealth position in Q3 2026.
BioStem Technologies made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #1477 holding.
13 funds tracked by Wall St. Rank held BioStem Technologies as of Q3 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.